Skip to main content
Clinical Trials/NCT02650583
NCT02650583
Completed
Not Applicable

Enhancing Connections Program in Palliative Care: Taking Care of the Children

University of Washington1 site in 1 country41 target enrollmentDecember 28, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Advanced Malignant Neoplasm
Sponsor
University of Washington
Enrollment
41
Locations
1
Primary Endpoint
Rate of receipt of mailed materials both to participants and from participants (e.g., signed consents, baseline data; parent's materials)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This pilot clinical trial studies the use of the Enhancing Connections Program in improving communication between patients with incurable cancer and their children. The Enhancing Connections Program is an educational program that may provide patients with new competencies to improve communication with their children and help them to cope with their parent's incurable cancer.

Detailed Description

PRIMARY OBJECTIVES: I. To test the feasibility of the study protocol in advanced cancer patients (recruitment/retention, dosage and fidelity of the intervention; program acceptability of program; and logistics). II. To evaluate the short-term impact of the program on the diagnosed parents' and children's adjustment using a within group design (pre- and post-test design). III. To compare outcomes from the Enhancing Connections Program with outcomes obtained from the completed Phase III trial (between group design). OUTLINE: Patients participate in Enhancing Connections Program comprising of anchoring patients to help their child, adding to listening skills, building on listening skills, being a detective of their child's coping, and celebrating success for 5 sessions. Patients also receive workbook which includes text from the sessions, handouts, and at-home assignments to be completed between sessions.

Registry
clinicaltrials.gov
Start Date
December 28, 2015
End Date
February 15, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Parents will be eligible if they have a diagnosis of incurable cancer of any type
  • Read and write English among their languages of choice
  • Have a child 5-17 years old living at home who has been told their parent's cancer diagnosis
  • The child does not have learning challenges

Exclusion Criteria

  • Parents will be excluded if they are enrolled in hospice at time of enrollment; (however, they will be allowed to continue in the study if they enroll in hospice after beginning the study)
  • Parents will be ineligible if their child lives in the home less than 50% of the time

Outcomes

Primary Outcomes

Rate of receipt of mailed materials both to participants and from participants (e.g., signed consents, baseline data; parent's materials)

Time Frame: Baseline

Differences between the telephone-delivered and the in-person delivered program

Time Frame: Up to 3 months

Linear mixed modeling based on maximum likelihood estimation will be used to test the differences between the telephone-delivered and the in-person delivered program.

Dosage and fidelity

Time Frame: Up to 3 months

Will be monitored for each intervention session using the performance checklists, the same checklists used to monitor dosage and fidelity in the Enhancing Connections (EC) trial. (Each session of the Program has its own unique Performance Checklist and each item is scored from 0-2. Performance Checklist items are specific to each session of the Program to be delivered by the patient educator. Higher scores denote higher performance by the patient educator and greater confidence that the Program was delivered as designed. The Performance Checklist is only used to monitor the performance of the

Number of patients recruited and retained, tracked on recruitment spreadsheets

Time Frame: Up to 3 months

Three methods of recruitment will be monitored: self-referral, provider referral, and recruitment letter.

Parent and child adjustment at completion of the EC-PC program, as measured by standardized questionnaire

Time Frame: Up to 3 months

Will be compared with outcomes obtained from the intervention group in the EC-RCT (historical comparison group).

Program acceptability (per session, overall, duration of program, interval between intervention sessions)

Time Frame: At Session 5, occurring within up to 3 months

Will be assessed from a debriefing interview in Session 5 that includes the parents' attributed gains of the program and their responses to the program's content, format, in-session, and at-home assignments.

Rate of success in scheduling and completing intervention sessions

Time Frame: At Session 5, occurring within up to 3 months

Change in EC-palliative care (PC) parents' and children's scores (parent-reported) on standardized questionnaires from baseline to post-intervention

Time Frame: Baseline to up to 3 months

Baseline scores will be compared with post-intervention scores on the same measures. Analysis of covariance will be used to test for significant differences between pre- and post-test scores.

Duration of intervention sessions

Time Frame: Up to 3 months

Percentage of participants who complete both baseline and post-intervention sets of questionnaires with no missing data

Time Frame: Up to 3 months

Assessed at baseline and post-intervention (up to 3 months).

Percentage of participants who return both baseline and post-intervention sets of questionnaires within 2 weeks of receipt

Time Frame: Up to 14 weeks

Assessed at baseline and post-intervention (up to 3 months).

Study Sites (1)

Loading locations...

Similar Trials